The estimated Net Worth of Ari Bousbib is at least $427 Millón dollars as of 1 March 2024. Mr. Bousbib owns over 42,847 units of IQVIA Inc stock worth over $196,586,439 and over the last 21 years he sold IQV stock worth over $208,753,193. In addition, he makes $22,139,800 as Chairman of the Board, President y Chief Executive Officer at IQVIA Inc.
Ari has made over 31 trades of the IQVIA Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 42,847 units of IQV stock worth $2,791,911 on 1 March 2024.
The largest trade he's ever made was selling 368,640 units of IQVIA Inc stock on 26 July 2018 worth over $45,007,258. On average, Ari trades about 30,172 units every 83 days since 2003. As of 1 March 2024 he still owns at least 828,430 units of IQVIA Inc stock.
You can see the complete history of Mr. Bousbib stock trades at the bottom of the page.
Ari Bousbib serves as Chairman of the Board, President, Chief Executive Officer of the Company. He assumed this position in October 2016 following the Merger of Quintiles and IMS Health. From 2010 until the Merger, Mr. Bousbib served as Chairman and CEO of IMS Health. Prior to joining IMS Health, Mr. Bousbib spent 14 years at United Technologies Corporation (“UTC”), an aerospace, defense and building systems company. From 2008 until 2010, he served as President of UTC’s Commercial Companies, with executive leadership responsibilities for the worldwide operations of Otis Elevator Company, Carrier Corporation, UTC Fire & Security and UTC Power Inc. From 2002 until 2008, Mr. Bousbib was President of Otis, and from 2000 to 2002, he served as its Chief Operating Officer. Prior to joining UTC, Mr. Bousbib was a partner at Booz Allen Hamilton. Mr. Bousbib currently serves on the board of directors of The Home Depot, Inc. and is a member of the Harvard Medical School Health Care Policy Advisory Council. He previously served on the board of directors of Best Buy, Inc. and was appointed by the President of the United States to serve on the President’s Commission on White House Fellowships. Mr. Bousbib holds a Master of Science Degree in Mathematics and Mechanical Engineering from the Ecole Superieure des Travaux Publics, Paris, and an M.B.A. from Columbia University. Because of Mr. Bousbib’s extensive leadership experience and service as our Chief Executive Officer, we believe Mr. Bousbib is well qualified to serve on the Board. Mr. Bousbib was designated for nomination to the Board pursuant to the Shareholders Agreement described herein.
As the Chairman of the Board, President y Chief Executive Officer of IQVIA Inc, the total compensation of Ari Bousbib at IQVIA Inc is $22,139,800. There are no executives at IQVIA Inc getting paid more.
Ari Bousbib is 59, he's been the Chairman of the Board, President y Chief Executive Officer of IQVIA Inc since 2016. There are 8 older and 9 younger executives at IQVIA Inc. The oldest executive at IQVIA Holdings Inc is Ronald Rittenmeyer, 72, who is the Independent Director.
Ari's mailing address filed with the SEC is , 2455 PACES FERRY RD., SE, ATLANTA, GA, 30339.
Over the last 7 years, insiders at IQVIA Inc have traded over $7,012,312,980 worth of IQVIA Inc stock and bought 83,468 units worth $15,560,595 . The most active insiders traders include John Connaughton, Pension Plan Investment Boa... y Group Holdings (Sbs) Adviso.... On average, IQVIA Inc executives and independent directors trade stock every 29 days with the average trade being worth of $160,151,634. The most recent stock trade was executed by Eric Sherbet on 27 August 2024, trading 1,300 units of IQV stock currently worth $320,229.
quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com
IQVIA Inc executives and other stock owners filed with the SEC include: